宝ホ
ン
連結
Takara Holdings Inc. ‐Consolidated‐要約損益計算書
Consolidated Statements of Income by Business Group (Summary)
要約
借対照表
Consolidated Balance Sheets (Summary)
宝酒造
Takara Shuzo Group
要約損益計算書
Statements of Income (Summary)
要約
借対照表
Balance Sheets (Summary)成
期
決算短信補足資料
Supplement for the Consolidated Financial Statements for the Year Ended March 31, 2008
タ
バ
Takara Bio Group
要約損益計算書
Statements of Income (Summary)
要約
借対照表
Balance Sheets (Summary)事業
種類
セ
メン
情報
Industry Segments Information
売
高及び営業損益
Sales and Operating Income.
成
期 業績
想
Financial forecast for the year ending March 31, 2009
宝ホ
ン
連結
Takara Holdings Inc. ‐Consolidated‐
宝酒造
Takara Shuzo Group
タ
バ
Takara Bio Group将来見通
関す
注意事項
資料中
当社
び当社
現
計画
見通
戦略
確信
う
歴史的事実
いも
将来
業績
関す
見通
あ
現時
い
入手可能
情報
得
当社経営
断
基
くも
す
重大
や
確実性
含
い
情報
得
多く
仮定
び考え
基
も
あ
す
実際
業績
要素
測
大
く異
結果
得
知
く
い
実際
業績
影響
え
要素
経済情勢
特
消費動向
替
変動
法律
行政制度
変化
競合会社
価格
製品戦略
力
当社
既存製品
び新製品
販売力
生産中断
当社
知
的所
権
対す
侵害
急速
術革新
重大
訟
け
利
決等
あ
す
業績
影響
え
宝ホ
ルディングス株式会社
I
室
Takara Holdings Inc. Investor Relations Office.
T
X
I
a
a
a
Forward-Looking Statements
Statements in this document, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management according to information available at the time of writing, they reflect many assumptions and opinions derived from information that includes major risks and uncertainties. Actual results may vary significantly from these forecasts due to various factors.
宝ホ
ン
連結
:Takara Holdings Inc. ‐Consolidated‐要約損益計算書
:Consolidated Statements of Income by Business Group (Summary)百万 :Millions of Yen 成 期
FY2007
実績 想 実績 増減 比 増減 比
Actual Forecast announced Nov.2007 Actual change % difference %
宝酒造
タ バ
そ 他
売 高
売 原価
売 総利益
運 費 保管料
広告 伝費
研究開発費
管理費 そ 他
販売費及び一般管理費
宝酒造
タ バ
そ 他
Change from FY2007 Change from forecast anounced Nov.2007 FY2008 / April 1, 2007-March 31, 2008
成 期 対前期 対 想
Takara Shuzo Group
Cost of sales Gross profit Other,net Takara Bio Group
Net sales
SG&A expenses Takara Shuzo Group Takara Bio Group Oth t
Transportation and storage
Other,net Advertising
Sales promotion and allowance for s.p.
販売 進費 販売 進引当金繰入
Research and development
68 109.7%
700
ᇞ 122 98.3%
7,300
560 775 - 360 280.0%
7,177 609 109.3%
1,307
ᇞ 215
ᇞ539 58.7%
768 6,568 29,582 3,900 21,882 68,550 200
ᇞ 792 98.8%
66,300 95.6%
103.0%
99.3%
98.5% 93.4%
65,507 ᇞ 3,042 716
ᇞ 3,061
50 43 29,373 3,643 21,553 127
ᇞ 208
ᇞ 256
ᇞ 328 90.6% 101.4% 100.2% 32,435 3,593 21,509 5,000 191,700 117,200 76,210 6,578 6,705 4,231
ᇞ 790 89.3%
7,369
119.7% 3,642
ᇞ 126
4,358
100.6% 100.1% 96.2%
664
ᇞ 188
178
98.1%
ᇞ 485 99.3%
198,535
74,500
117,864
74,014 ᇞ 2,196 97.1%
122,325 ᇞ 4,461 96.4%
174,143
20,982
3,409 4,811
ᇞ 7,355
ᇞ 703 20,278 166,400 20,300 95.8% 96.6% 100.2% 96.6%
ᇞ 6,657 191,878
141.1%
388
ᇞ 21 99.9%
1,401 166,788
営業利益 △:損失
利息 郤当金
そ 他営業外収益
Other,net
営業外収益
支払利息
そ 他営業外費用
Other,net
営業外費用
経常利益 △:損失
特 利益
特 損失
法人税 民税及び事業税
法人税等調整額
少数株主利益 △:損失
設備投資額 形 無形
減価償却費 形 無形
営業外収益 利息 郤当金 持分法 投資利益 託研究補助金
Non-operating income Interest income 296, Dividend income 423, Equity in earnings of associated companies 566, Grant received for R&D 38, etc.
営業外費用 支払利息 社債利息 棚卸資産廃棄 欠減損 社債発行費
Non-operating expenses Interest expense 258, Bond interest 266, Loss on disposals of inventories 224, Bond issue expensese 76 etc.
特 利益 投資 価証券売却益 持分変動利益 営業権権等売却益 固定資産売却益
99.5% Interest and discounts expenses
476 637 554 77 116.3% ᇞ 83 86.9%
ᇞ 3
277 80
158.6%
137.9%
524 562 559 34 106.6%
108.6%
453 669 719 265 50 107.5%
733 930 1,010
Net income(△:loss) Other,net
当期純利益 △:損失
Extraordinary gain Extraordinary loss
Current income taxes Deferred income taxes Non-operating income
Non-operating expenses
Ordinary income(△:loss)
Operating income(△:loss) Interest income Dividends income
税金等調整前当期純利益 △:損失
Minority interests in net income△:loss
Income(△:loss) before income taxes and minority interests
270 -
0
ᇞ 206 94.3%
3,600
270 140 208.5%
129
ᇞ 405 3 -
ᇞ 408
3,798 67 101.8% 3,731
591 132.9%
1,800
8,321 661 108.6% 2,391 584 132.3%
7,660 7,900 421 105.3%
1,807
523 106.1%
8,600
1,590 ᇞ 32 98.0%
1,622 490 144.6%
92.8% 1,200
1,000
1,100
9,123 1,277 116.3%
306 103.7%
8,200
1,113 112 111.2% 8,506 845 111.0%
ᇞ 86
130 108.2%
1,600 1,730 543 145.8%
, 4,208 1,186 7,660 7,846 358 108.3%
4,300 4,658 450 110.7%
ᇞ 1,847 67.6% 5,700
Capital expenditures 3,617 3,852 234 106.5%
ᇞ 144 97.4%
5,600
Depreciation 5,710 5,455 ᇞ 254 95.5%
Extraordinary gain Gain on sales of investment securities 1,178, Gain resulting from change in ownership in subsidiaries 215, Gain on sales of trademark and other rights 75, Gain on sales of property, plant and equipment 40, etc. 特 損失 和解費用 固定資産売却 却損 投資 価証券評価損 減損損失
Extraordinary loss Loss on settlement payment of lawsuite 1,172, Loss on disposals of property, plant and equipment 333, Loss on write-down of investment securities 449, Impairment loss 170, etc.
要約
借対照表
:Consolidated Balance Sheets (Summary)資産の部
:Assets 百万 :Millions of Yen成
3
期
成
3
期
増減
主
増減理由
FY2007 FY2008 change Reference
流動資産
(Total current assets)
億 :One hundred millions of Yen
現金及び預金
T etcCash and deposits
手形及び売掛金
TS△ etcNotes and accounts receivable-trade, net
価証券
TH TS T etcMarketable securities
卸資産
T △ etcInventories
そ
他
T △ TH TS etcOther current assets
倒引当金
Allowance for doubtful accounts
固定資産
T a x a
形固定資産
当期 形 無形固定資産 増減Property, plant and equipment Reference of Property, plant and equipment and Intangible assets
建物及び構築物
新規 得 + TS T etcB ildi d t t N l h +
120,796
112,666
8,130
26,529
22,778
3,750
46,990
51,274
ᇞ
4,283
18,132
6,690
11,441
25,096
25,436
ᇞ
340
4,209
6,643
ᇞ
2,433
ᇞ
160
ᇞ
156
ᇞ
3
87,047
100,726
ᇞ
13,679
47,341
49,544
ᇞ
2,203
16 387
17 020
ᇞ
632
Buildings and structures Newly purchases +
機械装置及び運搬具
減価償却 △ TS △ T △ etcMachinery, equipment and vehicles Depreciation △54.6
土地
そ 他増減 △Land Other,net △9.5
そ
他
Other property, plant and equipment
無形固定資産
Intangible fixed assets
投資そ
他
資産
Investments and other assets
投資
価証券
TH△ T △ etcInvestment securities (TH Write-down loss △84.2, redemption/seles △
Impairment loss △3.9 etc.)
そ
他
TS+ T △ etcOther assets
倒引当金
Allowance for doubtful accounts
資産合計
Total assets
TH
=
Takara Holdings Inc. TS
=
Takara Shuzo Group TB
=
Takara Bio Group
16,387
17,020
ᇞ
632
13,059
14,651
ᇞ
1,591
14,547
14,825
ᇞ
277
3,345
3,046
298
6,561
6,908
ᇞ
346
33,144
44,273
ᇞ
11,129
26,122
36,970
ᇞ
10,847
207,843
213,393
ᇞ
5,549
7,427
7,851
ᇞ
423
ᇞ
405
ᇞ
547
142
要約
借対照表
:Consolidated Balance Sheets (Summary)
負債及び純資産
の部
:Liabilities and net assets 百万 :Millions of Yen成
3
期
成
3
期
増減
主
増減理由
FY2007 FY2008 change Reference
流動負債
(Total current liabilities)
億 :One hundred millions of Yen
支払手形及び
掛金
TS△ B△ そ 他(other)+ etcNotes and accounts payable-trade
短期借入金
Short-term loans payable
1
償還
社債
TH 償還第回普通社債Current portion of bonds (unsecured bonds, due May 2008)
払酒税
TS△Accrued alcohol tax
払費用
TS△ そ 他(other)△ etcAccrued expenses
販売
進引当金
そ
他
Other current liabilities
固定負債
(Total non-current liabilities)
社債
TH 社債発行 返済流動負債へ△Bonds payable (Issuance of bonds+100, To current portion △ )
長期借入金
Long-term loans payable
職給付引当金
TS+ etcReserve for retirement benefits
預
金
△ etcDeposits from customers
そ
他
H繰延税金負債 Deferred tax liabilities △ etc Other non-current liabilities負債合計
Total liabilities
資
金
Capital stock
資
剰余金
Capital surplus
利益剰余金
Retained earnings
自己株式
Treasury stock
株主資
(Total owner's equity)
そ
他
価証券評価差額金
TH△ etc繰延
ッ
損益
替換算調整勘定
T △ etc評価
換算差額等
少数株主持分
(Minority interests)
純資産合計
Net assets
負債純資産合計
Total liabilities and net assets
TH
=
Takara Holdings Inc. TS
=
Takara Shuzo Group TB
=
Takara Bio Group
113,273
115,570
ᇞ
2,297
207,843
213,393
ᇞ
5,549
ᇞ
514
12,740
ᇞ
5,531
13,303
13,062
241
7,208
92,761
89,767
575
1,090
5
ᇞ
52
6,679
11,644
ᇞ
4,964
ᇞ
46
Reserve for sales promotion expenses13,226
13,226
-
94,570
97,823
ᇞ
3,252
6,639
7,043
ᇞ
403
Valuation difference on available-for-sale securities
Deffered gains or losses on hedges
Translation adjustments
(Total valuation and translation adjustments)
2,993
3,204
3,205
ᇞ
1
77,342
74,308
3,034
ᇞ
1,011
ᇞ
972
ᇞ
39
5,705
9,173
ᇞ
3,468
5,718
5,739
ᇞ
21
8,899
8,690
209
46,963
45,646
1,316
20,000
15,000
5,000
1,466
1,366
99
9,614
9,704
ᇞ
90
7,784
10,288
ᇞ
2,503
4,475
7,354
ᇞ
2,878
4,964
4,903
61
5,000
5,000
-
47,607
52,176
ᇞ
4,568
14,301
13,558
743
宝酒造
:Takara Shuzo Group要約損益計算書
:Statements of Income (Summary)百万 :Millions of Yen
成
期
FY2007
実績
想
実績
増減 比 増減 比Actual Forecast announced Nov.2007 Actual change % difference %
焼郥
清酒
ソフ
コ
飲料
そ
他酒類
そ
他調味料
飲料
原料用
コ
等
そ
他
売
高
売
原価
売
総利益
運
費
保管料
広告
伝費
149.1% 66
100.2%
6,994
11,350
Other 7,655 3,760
109,200 166,400 104,000
6,064
11,416
Beveragesᇞ 41 99.2% 4,941
Raw alcohol
4,900
ᇞ 876 84.8%7,255 19 2 110.5%
99.4% 16,172
Hon Mirin
108.3%
5,130 5,602 ᇞ 47 99.1%
100.1%
16,062 ᇞ 100
ᇞ 4,382
ᇞ 7,355
86.7% 5,776
ᇞ 41
99.9% 73,757
23,841
106.7%
19,934
成
期
ᇞ 77
ᇞ 63
対前期 対 想
FY2008(April 1, 2007 - March 31, 2008) Change from FY2007 Change from forecast anounced Nov.2007
ᇞ 403
601
11,432
71998.3%
19,362
ᇞ 4,358
5,554
424 8 103.1% 78,037 24,181 19,33273,679
23,777
94.4% 571 388 100.7% 62,400104,818
61,970
ᇞ 2,973 95.4%818 96.0%
102.9% 99.7%
64,943 ᇞ 429 99.3%
174,143
100.6%
10,712 80
100.8%
21
ᇞ 7,233 0.3%95.8%
166,788
ᇞ 929
6,106 99.3%
Transportation and storage
11,351
16,071
ShochuCost of sales Gross profit Light-alcohol refreshers Sake Net sales Other liquors Other seasonings
広告
伝費
研究開発費
商標使用料
管理費
そ
他
販売費及び一般管理費
営業利益
△:損失
営業外収益
営業外費用
経常利益
△:損失
特
利益
特
損失
法人税
民税及び事業税
法人税等調整額
少数株主利益
△:損失
設備投資額
形
無形
減価償却費
形
無形
1,467 1,589
113.4%
90.1%
92.4%
ᇞ 3,086
License for use of trademarks
ᇞ 109
ᇞ 1,430
97.3% 4,000
Depreciation 3,958
3,890
ᇞ 67 98.3%60.9% 3,660
Capital expenditures 2,573
2,229
ᇞ 343 86.6%ᇞ 6
88
ᇞ 120
3,995
28,052
350
14,858
471 3,81354,792
1,469
58,375 2 3,523 31,139 357 98.0% 98.3% 14,770 100.6%ᇞ 122
585 609 109.3% 7,300 112.9% 104.8% 99.3% 98.6% 87.7%
ᇞ 49
ᇞ 207 182
ᇞ 195
100.2%
100.2% 3,600
ᇞ 307 99.4%
55,100 93.9%
883 132.4%
92.9%
ᇞ 3,583 28,248
400
15,066
3,607
655 ᇞ 49
7,100
7,177
6,498 700 2,723 7 6,568500
564
ᇞ 20ᇞ 7 96.4%
5,544
5
99.9% 64
650
ᇞ 5 99.1%ᇞ 159 40.0%
7,092
594 109.1%66
265 100 106.0%
231
ᇞ 986 19.0%1,218 300 ᇞ 68 77.3%
105
101.0% 6,900
6,966
1,422 125.6%ᇞ 9 96.4% 254
3,433
793 130.0%2,640
ᇞ 74
122.7% 200
14 100.5% 3,100
ᇞ
319
ᇞ 245 -45
245
Non-operating income Non-operating expenses
Ordinary income(△:loss)
Other,net Advertising
Sales promotion and allowance for s.p.
販売
進費
販売
進引当金繰入
Operating income(△:loss) Research and development
Net income(△:loss) SG&A expenses
当期純利益
△:損失
Extraordinary gain Extraordinary loss
Current income taxes Deferred income taxes
税金等調整前当期純利益
△:損失
Minority interests in net income △:loss
Income(△:loss) before income taxes and minority interests
要約
借対照表
:Balance Sheets (Summary)資産の部
:Assets 百万 :Millions of Yen成
3
期
成
3
期
増減
主
増減理由
FY2007 FY2008 change Reference
流動資産
(Total current assets)
億 :One hundred millions of Yen
現金及び預金
Cash and deposits
手形及び売掛金
主 売 高減少Notes and accounts receivable-trade, net a a Taaa z
価証券
N etcMarketable securities
卸資産
Inventories
そ
他
繰延税金資産 eferred tax assets etc Other current assets倒引当金
Allowance for doubtful accounts
固定資産
T a x a
形固定資産
当期 形 無形固定資産 増減Property, plant and equipment Reference of Property, plant and equipment and Intangible assets
建物及び構築物
新規 得 +B ildi d t t N l h 22 3
30,570
32,198
ᇞ
1,627
11 852
12 255
ᇞ
402
ᇞ
45
ᇞ
75
29
38,501
39,855
ᇞ
1,353
21,614
21,645
ᇞ
31
3,935
3,690
244
40,515
44,657
ᇞ
4,141
3,821
1,012
2,809
78,595
79,782
ᇞ
1,186
8,755
8,851
ᇞ
96
Buildings and structures Newly purchases +22.3
機械装置及び運搬具
減価償却 △Machinery, equipment and vehicles Accumulated depreciation △
土地
そ 他増減 △Land Other,net △
そ
他
Other property, plant and equipment
無形固定資産
Intangible fixed assets
投資そ
他
資産
Investments and other assets
投資
価証券
Investment securities
そ
他
繰延税金資産 eferred tax assets etc Other assets倒引当金
Allowance for doubtful accounts
資産合計
Total assets
119,637
117,097
ᇞ
2,540
4,245
3,833
412
ᇞ
237
ᇞ
201
ᇞ
36
6,009
5,500
509
2,001
1,868
133
1,154
1,158
ᇞ
3
1,921
2,156
ᇞ
234
10,600
11,832
ᇞ
1,231
6,962
6,952
10
11,852
12,255
ᇞ
402
要約
借対照表
:Balance Sheets (Summary)負債及び純資産
の部
:Liabilities and net assets 百万 :Millions of Yen成
3
期
成
3
期
増減
主
増減理由
FY2007 FY2008 change Reference
流動負債
(Total current liabilities)
億 :One hundred millions of Yen
支払手形及び
掛金
宝酒造 Takara Shuzo △ etcNotes and accounts payable-trade
短期借入金
Short-term loans payable
払酒税
主 3 休日 増加Accrued alcohol tax End of the month (payment day) The bank holiday in 2007
払費用
宝酒造 Takara Shuzo △ etcAccrued expenses
販売
進引当金
そ
他
払法人税等 払金△ etcOther current liabilities Accounts payable △10.0, Accrued income taxes +8.5 etc.
固定負債
(Total non-current liabilities)
長期借入金
Long-term loans payable
職給付引当金
Reserve for retirement benefits
預
金
宝酒造 引保証金返金Deposits from customers Ta aa x
そ
他
Other non-current liabilities
負債合計
Total liabilities
資
金
Capital stock
資
剰余金
Capital surplus
利益剰余金
Retained earnings
株主資
(Total owner's equity)
そ
他
価証券評価差額金
繰延
ッ
損益
替換算調整勘定
評価
換算差額等
少数株主持分
(Minority interests)
純資産合計
Net assets
負債純資産合計
Total liabilities and net assets
3,293
2,738
2,464
273
117,097
119,637
ᇞ
2,540
69,864
68,346
1,517
67,062
65,455
1,607
ᇞ
46
5
ᇞ
52
32,593
36,449
ᇞ
3,856
11,813
12,180
ᇞ
367
740
649
90
7,784
10,288
ᇞ
2,503
4,138
ᇞ
844
1,466
1,366
99
7,495
7,826
ᇞ
331
14,639
14,841
ᇞ
201
116
93
23
7,605
7,438
167
6,609
7,013
ᇞ
404
56,678
56,678
-
307
295
12
47,232
51,290
ᇞ
4,058
(Total valuation and translation adjustments)
32
192
ᇞ
159
63
426
78
229
ᇞ
151
ᇞ
363
1,607
Reserve for sales promotion expensesValuation difference on available-for-sale securities
Deffered gains or losses on hedges
Translation adjustments
9,384
7,777
1,000
1,000
-
タ
バ
:Takara Bio Group要約損益計算書
:Statements of Income (Summary)百万 :Millions of Yen
成
期
FY2007
実績
想
実績
増減 比 増減 比Actual Forecast announced Nov.2007 Actual change % difference %
研究用試薬
理化学機器
託
そ
他フ
ン
遺伝子工学研究
計
遺伝子医療
医食品バ
売
高
売
原価
売
総利益
運
費
保管料
広告
伝費
研究開発費
商標使用料
Research reagents
Cost of sales Gross profit
Contracted service and other Scientific instruments
Net sales
Transportation and storage Advertising
Sales promotion
販売
進費
Research and development
94.3%
94.1% 260
77
1,183
3,502 56 ᇞ 206
85
1,336
3,239 101.8%
99.9%
61.1%
ᇞ 25
ᇞ 221
ᇞ 17
ᇞ 67
76.1%
77.8%
ᇞ 125
70.5%
83.5%
ᇞ 62
111.0% 104.8%
9,821 ᇞ 6 99.9%
20,982 18,572
99.9% 100.6%
401 104.1%
ᇞ 14 11,160 10,069 ᇞ 1,105 90.1%
20,278
ᇞ 2199.9% 12,666 3,172 2,734 97.4% 2,459 20,300
2,730
106ᇞ 3
18,080
ᇞ 4911,968
ᇞ 258271 12,980
2,534
成
期
ᇞ 287
122
12,692
2,657
100.2% 26
ᇞ 514
182 210 18 108.9%
17,974 Genetic engineering research segment
229
46Gene medicine segment 125.7%
88.4% ᇞ 146 93.1%
ᇞ 703
10,230
10,055
10,223
Agribio segment 2,226
197
3,296
32360
1,115
96.6%対前期 対 想
FY2008(April 1, 2007 - March 31, 2008) Change from FY2007 Change from forecast anounced Nov.2007
2,114
83.8%
97.8%
商標使用料
管理費
そ
他
販売費及び一般管理費
遺伝子医療
医食品バ
共通
営業利益
△:損失
営業外収益
営業外費用
経常利益
△:損失
特
利益
特
損失
法人税
民税及び事業税
法人税等調整額
少数株主利益
△:損失
設備投資額
形
無形
減価償却費
形
無形
114 - ᇞ 1,721
Eliminations/Corporate ᇞ 1,574
ᇞ
1,607
ᇞ 32 -Agribio segment ᇞ 1,232
ᇞ
782
450 -98 - ᇞ 1,317
ᇞ 162 - ᇞ 619
Net income(△:loss) SG&A expenses
当期純利益
△:損失
Extraordinary gain Extraordinary loss
Current income taxes Deferred income taxes
税金等調整前当期純利益
△:損失
Minority interests in net income △:loss
Income(△:loss) before income taxes and minority interests Non-operating income
Non-operating expenses
Ordinary income(△:loss)
Other,net
Operating income(△:loss)
79.7% 12
133 - ᇞ 151
ᇞ
263
40347 -
ᇞ 2
9
45 -ᇞ 36
780 295 178.7%
375 ᇞ 108 -
ᇞ 311
246
ᇞ 157 61.0%671
390 1,228 172 114.1%
166.4% 719
1,400
1,010 358.5%495 170.7%
700 477
65 400 476 219.0%
280.0% 200
876
810 1329.6%560
775 - ᇞ 215117 117 ᇞ 35 70.0%
399 317 80 125.5%
360
649 2265.0% 30
398
0 99.8%82
ᇞ 35 69.8%1,196
679
359 212.2% 32099.7%
10,037 ᇞ 366 96.3%
4,996 ᇞ 58 ᇞ 13 0
10,030
0
9,663
ᇞ 373 96.3%5,041 10
98.8%
101.5% 100.3%
ᇞ 431 77.7% 1,937
Capital expenditures 952
1,505
553 158.1%ᇞ96 93.7% 1,525
Depreciation 1,608
1,429
ᇞ179 88.8%310 108.0% 3,858
遺伝子工学研究
4,168
3,4564,983
10
Genetic engineering research segment
ᇞ
1,219
ᇞ 354 -Gene medicine segment
711 120.6%
ᇞ 865
10 License for use of trademarks
Depreciation
,
要約
借対照表
:Balance Sheets (Summary)資産の部
:Assets 百万 :Millions of Yen成
3
期
成
3
期
増減
主
増減理由
FY2007 FY2008 change Reference
流動資産
(Total current assets)
億 :One hundred millions of Yen
現金及び預金
タ バ ン ッCash and deposits Takara Bio +2,840 ,Clontech +460
手形及び売掛金
タ バ Takara io △ etcNotes and accounts receivable-trade, net
価証券
タ バ 運用債券 etcMarketable securities Operating debenture 20.0 etc.
卸資産
ン ッ lontech △ etcInventories
そ
他
タ バ 信託 益権△ タ コ △ etcOther current assets Trust beneficiary right (Takara Bio Inc.) △20.0 etc.
Takara Korea Biomedical △
倒引当金
Allowance for doubtful accounts
固定資産
T a x a
形固定資産
当期 形 無形固定資産 増減Property, plant and equipment Reference of Property, plant and equipment and Intangible assets
建物及び構築物
新規 得 +B ildi d t t N l h 15 1
25,417
23,700
1,716
8,653
5,166
3,487
5,659
5,770
ᇞ
111
7,310
5,678
1,632
3,176
3,493
ᇞ
316
725
3,665
ᇞ
2,939
ᇞ
108
ᇞ
73
ᇞ
34
19,871
21,839
ᇞ
1,967
12,356
12,416
ᇞ
60
3 759
3 856
ᇞ
97
Buildings and structures Newly purchases +15.1
機械装置及び運搬具
減価償却 △Machinery, equipment and vehicles Accumulated depreciation △14.3
土地
そ 他増減 △Land Other,net △2.4
そ
他
Other property, plant and equipment
無形固定資産
Intangible fixed assets
投資そ
他
資産
Investments and other assets
投資
価証券
投資 価証券 関 会社株式 出資金 △Investment securities Investment securities +2.8,
Investments in capital of affiliates △14.6
そ
他
長期前払費用△ etcOther assets Long-term prepaid expenses △
倒引当金
Allowance for doubtful accounts
資産合計
Total assets
3,759
3,856
ᇞ
97
2,262
2,641
ᇞ
379
4,633
4,529
103
1,701
1,388
313
4,432
4,533
ᇞ
101
3,083
4,889
ᇞ
1,805
404
1,586
ᇞ
1,181
45,289
45,539
ᇞ
250
2,679
3,505
ᇞ
826
0
ᇞ
202
202
要約
借対照表
:Balance Sheets (Summary)負債及び純資産
の部
:Liabilities and net assets 百万 :Millions of Yen成
3
期
成
3
期
増減
主
増減理由
FY2007 FY2008 change Reference
流動負債
(Total current liabilities)
億 :One hundred millions of Yen
支払手形及び
掛金
タ バ Takara io △ etcNotes and accounts payable-trade
短期借入金
Short-term loans payable
そ
他
払金△ 払費用△ etcOther current liabilities Other accounts payable△ x △
固定負債
(Total non-current liabilities)
長期借入金
Long-term loans payable
職給付引当金
Reserve for retirement benefits
そ
他
Other non-current liabilities
負債合計
Total liabilities
資
金
Capital stock
資
剰余金
Capital surplus
利益剰余金
Retained earnings
自己株式
Treasury stock
株主資
(Total owner's equity)
そ
他
価証券評価差額金
繰延
ッ
損益
替換算調整勘定
評価
換算差額等
少数株主持分
(Minority interests)
純資産合計
Net assets
負債純資産合計
Total liabilities and net assets
0
ᇞ
3
3
26,949
Valuation difference on available-for-sale securities
Deffered gains or losses on hedges
Translation adjustments
(Total valuation and translation adjustments)
289
0
26,904
989
1,211
700
1,211
ᇞ
510
ᇞ
221
45
2,035
1,358
677
6,180
6,926
ᇞ
745
9,022
8,976
45
1,115
1,121
ᇞ
5
501
546
ᇞ
44
922
889
33
2,374
2,749
ᇞ
375
2,539
2,556
ᇞ
17
44
44
0
3,641
4,369
ᇞ
728
1,221
1,574
ᇞ
353
38,007
37,236
771
0
0
-
289
110
165
ᇞ
54
45,289
45,539
ᇞ
250
39,108
38,613
495
事業
種類
セ
メン
情報
:Industry Segments Information売
高及び営業損益
:Sales and Operating Income
売上高
:Total sales 百万 :Millions of Yen増減 比
change %
酒類
食品
Alcoholic Beverages and Foods179,794
178,277
176,626
174,143
-
- -バ
Biomedical13,592
13,685
16,534
20,982
-
- -そ
他
Other11,153
10,890
11,975
11,148
-
- -消去又
全社
Eliminations/Corporateᇞ
7,643
ᇞ
7,494
ᇞ
9,017
ᇞ
7,738
-
- -酒類
調味料
Alcoholic Beverages and Seasonings-
-
-
168,040
157,638
ᇞ 10,401 93.8%バ
Biomedical-
-
-
20,982
20,278
ᇞ 703 96.6%物流
Transportation-
-
-
14,415
16,685
2,269 115.7%そ
他
Other-
-
-
11,148
12,729
1,581 114.2%消去又
全社
Eliminations/Corporate-
-
-
ᇞ
16,050
ᇞ
15,453
597 96.3%連結
Consolidated196,897
195,359
196,119
198,535
191,878
ᇞ 6,657 96.6%営業費用
:Operating expenses酒類
食品
Alcoholic Beverages and Foods169,708
169,632
169,020
165,986
-
- -バ
Biomedical13,832
14,762
18,010
21,187
-
- -そ
他
Other10,842
10,256
11,282
10,663
-
- -消去又
全社
Eliminations/Corporateᇞ
6,845
ᇞ
6,694
ᇞ
8,118
ᇞ
6,961
-
- -郤賦 能営業費用Unallocated operating expenses 964 925 983 978 - - -
酒類
調味料
Alcoholic Beverages and Seasonings-
-
-
160,342
149,450
ᇞ 10,892 93.2%バ
Biomedical-
-
-
21,187
19,707
ᇞ 1,479 93.0%物流
Transportation-
-
-
13,960
16,236
2,275 116.3%そ
他
Other-
-
-
10,663
12,705
2,042 119.2%消去又
全社
Eliminations/Corporate-
-
-
ᇞ
15,278
ᇞ
14,728
96.4%郤賦 能営業費用Unallocated operating expenses - - - 978 956 △ 97.8%
連結
Consolidated187,537
187,956
190,194
190,875
183,371
ᇞ 7,503 96.1%営業利益
△:損失
:Operating income(△:loss)酒類
食品
Alcoholic Beverages and Foods10,086
8,644
7,605
8,157
-
- -バ
Biomedicalᇞ
239
ᇞ
1,076
ᇞ
1,476
ᇞ
205
-
- -そ
他
Other310
634
693
485
-
- -消去又
全社
Eliminations/Corporateᇞ
797
ᇞ
799
ᇞ
898
ᇞ
777
-
- -酒類
調味料
Alcoholic Beverages and Seasonings-
-
-
7,697
8,187
490 106.4%バ
Biomedical-
-
-
ᇞ
205
570
775 -物流
Transportation-
-
-
455
448
ᇞ 6 98.6%そ
他
Other-
-
-
485
23
ᇞ 461 4.9%消去又
全社
Eliminations/Corporate-
-
-
ᇞ
772
ᇞ
724
47 %連結
Consolidated9,360
7,402
5,924
7,660
8,506
845 111.0%FY2004 FY2005 FY2006 FY2007 FY2008
成
期
成
期
成
期
成
期
成
期
前期対比 hange from FY
資産
減価償却費
減損損失及び資
的支出
:Assets, Depreciation, Impairment loss and Capital Expenditures
資産
:Assets 百万 :Millions of Yen増減 比
change %
酒類
食品
Alcoholic Beverages and Foods121,320
115,428
116,533
119,637
-
- -バ
Biomedical31,649
37,427
44,443
45,539
-
- -そ
他
Other7,429
7,351
11,732
11,759
-
- -消去又
全社
Eliminations/Corporate29,017
30,566
39,757
36,456
-
- -酒類
調味料
Alcoholic Beverages and Seasonings-
-
-
115,555
112,941
ᇞ 2,614 97.7%バ
Biomedical-
-
-
45,539
45,289
ᇞ 250 99.5%物流
Transportation-
-
-
5,745
5,561
ᇞ 183 96.8%そ
他
Other-
-
-
11,759
11,068
ᇞ 691 94.1%消去又
全社
Eliminations/Corporate-
-
-
34,793
32,983
ᇞ 1,809 94.8%連結
Consolidated189,416
190,773
212,466
213,393
207,843
ᇞ 5,549 97.4%減価償却費
:Depreciation酒類
食品
Alcoholic Beverages and Foods4,035
4,127
4,275
3,958
-
- -バ
Biomedical1,271
1,304
1,477
1,608
-
- -そ
他
Other164
137
120
115
-
- -消去又
全社
Eliminations/Corporate93
58
36
27
-
- -酒類
調味料
Alcoholic Beverages and Seasonings-
-
-
3,719
3,596
ᇞ 123 96.7%バ
Biomedical-
-
-
1,608
1,429
ᇞ 179 88.8%前期対比 hange from FY
FY2004 FY2005 FY2006 FY2007 FY2008
成
期
成
期
成
期
成
期
成
期
物流
Transportation-
-
-
238
294
56 123.5%そ
他
Other-
-
-
115
114
ᇞ 1 98.4%消去又
全社
Eliminations/Corporate-
-
-
27
21
△ 80.5%連結
Consolidated5,565
5,628
5,910
5,710
5,455
ᇞ 254 95.5%減損損失
:Impairment loss酒類
食品
Alcoholic Beverages and Foods0
0
0
0
-
- -バ
Biomedical0
0
0
0
-
- -そ
他
Other0
0
0
0
-
- -消去又
全社
Eliminations/Corporate0
3,469
0
0
-
- -酒類
調味料
Alcoholic Beverages and Seasonings-
-
-
0
0
- -バ
Biomedical-
-
-
0
0
- -物流
Transportation-
-
-
0
0
- -そ
他
Other-
-
-
0
0
- -消去又
全社
Eliminations/Corporate-
-
-
0
170
-連結
Consolidated0
3,469
0
0
170
170 -資本的支出
:Capital Expenditures酒類
食品
Alcoholic Beverages and Foods3,961
4,378
4,253
2,573
-
- -バ
Biomedical1,230
2,086
1,264
952
-
- -そ
他
Other36
44
110
96
-
- -消去又
全社
Eliminations/Corporate15
1
5
ᇞ
4
-
- -酒類
調味料
Alcoholic Beverages and Seasonings-
-
-
2,179
1,764
ᇞ 414 81.0%バ
Biomedical-
-
-
952
1,505
553 158.1%物流
Transportation-
-
-
394
465
70 117.9%そ
他
Other-
-
-
96
116
20 121.2%消去又
全社
Eliminations/Corporate-
-
-
ᇞ
4
0
-連結
Consolidated5,243
6,511
5,633
3,617
3,852
234 106.5%成
期 業績
想
:Financial forecast for the year ending March 31, 2009宝ホ
ン
連結
:Takara Holdings Inc. ‐Consolidated‐百万 :Millions of Yen
成
成
成 成期実績
期
想
中間期実績 中間期 想FY2008 FY2009 増減 比 FY2008(1
st
Half)FY2009(1st Half)
増減 比
Actual Forecast change % Actual Forecast change %
宝酒造
タ
バ
そ
他
売
高
売
原価
売
総利益
運
費
保管料
広告
伝費
研究開発費
管理費
そ
他
販売費及び一般管理費
宝酒造
10,929
32,600
2,100
前期対比
Change from FY2008(1st
Half) 106.5% 250 103.3% 100.1% 4 100.5% 100.0% 99.1% 97.9% 166,788 20,278
ᇞ 19 4,811
5,400
168,800
20,300
ᇞ 93
288
2,699
3,278
2,153
14,338
1051,900
112.2% 2,011 21 2,534 101.2% 100.1% 42ᇞ 202
164 79,257 9,403
79,300
9,201
99.3% 191,87891,200
34,500
34,753118,900
91,195 56,441 101.4% 2,621 117,86474,014 1,585 102.1%
258 100.9%
ᇞ 253
75,600
56,700
194,500
5884,325
29,815
6,860
281 1,035 4,358 29,373 3,643 21,553 3,173 2,172 104.3% 6,5784,300
21,698
102.3% 99.2% 101.5% 118.0% 100.7%ᇞ 33
656 144 99.4% 102.3% 117.9% 530 101.7% 32,069 14,432 1,611 10,679 65,507 442
67,000
322 104.5% ᇞ 32 7,177
1,492
98.5% 2,132
7,500
Change from FY2008
前期対比
Research and development Transportation and storage
Other,net Advertising
販売
進費
販売
進引当金繰入
Sales promotion and allowance for s.p.
SG&A expenses Takara Shuzo Group Takara Shuzo Group
Cost of sales Gross profit Other,net Takara Bio Group
Net sales
タ
バ
そ
他
営業利益
△:損失
利息
郤当金
そ
他営業外収益
Other,net
営業外収益
支払利息
そ
他営業外費用
Other,net
営業外費用
経常利益
△:損失
特
利益
特
損失
法人税
民税及び事業税
法人税等調整額
少数株主利益
△:損失
設備投資額
形
無形
減価償却費
形
無形
125.9%
324
82
ᇞ 241 25.6% 554259
ᇞ 294 46.8%251
317
391
208
ᇞ 12
ᇞ 59
81 114.6% 65
332
559640
32.9% 404 267269
2,400
Interest income Dividends incomeInterest and discounts expenses
719
667
1,010
Depreciation 5,455
5,600
144 102.6%1,100
-
4,700
41 100.9%ᇞ 59 97.8% 2,659
2,600
1,760
Capital expenditures 3,852
4,300
447 111.6% - -ᇞ 149 88.1% 1,249
ᇞ
469
4,658
1,730
1,000
ᇞ 730 57.8%768
1,000
231 130.2%100
ᇞ 460 17.9%560 232 ᇞ 701 -
89.3% 671
ᇞ 50 84.2% 319
ᇞ 784
1,900
600
96.9% 77.9% 69.5% 575 1,1132,100
70.8% 2,684900
ᇞ 213 80.8%400
8,5069,123
ᇞ 175
8,600
93 101.1%ᇞ 71
ᇞ 52
ᇞ 678
92.8%
ᇞ 1,432 -
1,590 863 ᇞ 563 34.7%
2,391
300
1,432
75.5% 2,780
300
ᇞ 1,290 18.9%0
8,700
ᇞ 423 95.4% ᇞ 680ᇞ 405
2,211
ᇞ 211 1,135
8,800
478 105.7%8,321
4,000
606 117.9%3,798
200
ᇞ 2,191 8.4%108.5%
ᇞ 138 -
38
476 151.6%
ᇞ
100
1,400
Minority interests in net income △:loss
Income(△:loss) before income taxes and minority interests
Deferred income taxes
100
ᇞ 170 37.0% 270188 Non-operating income
Non-operating expenses
Ordinary income(△:loss)
Operating income(△:loss)
Net income(△:loss) Takara Bio Group Other,net
当期純利益
△:損失
Extraordinary gain
税金等調整前当期純利益
△:損失
Extraordinary loss
Current income taxes
宝酒造
:Takara Shuzo Group百万 :Millions of Yen
成
成
成 成期実績
期
想
中間期実績 中間期 想FY2008 FY2009 増減 比 FY2008(1
st
Half)FY2009(1st Half)
増減 比
Actual Forecast change % Actual Forecast change %
焼郥
清酒
ソフ
コ
飲料
そ
他酒類
そ
他調味料
原料用
コ
等
そ
他
売
高
売
原価
売
総利益
運
費
保管料
広告
伝費
Shochu
Cost of sales Gross profit Light-alcohol refreshers Sake Net sales Other liquors Raw alcohol Other seasonings Other
Transportation and storage Advertising
販売
進費
販売
進引当金繰入
Sales promotion and allowance for s p 13,788
102.7%
94.6%
98.8% 2,879
2,030
ᇞ 162 3,995
28,052
28,392
340 101.2%77
1,920
13,626
3,893
ᇞ 102 97.4% ᇞ 1096,267
203 103.4%6,064
101.3%
11,432 ᇞ 353 93.5%
61,970 ᇞ 325 98.9%
166,788 79,257
29,025
106,200
62,600
629 101.0%50,232 73,679 23,777 19,934 95.4%
10,902
20,937
935ᇞ 426
1,003
ᇞ 185
ᇞ 383
452 42 105.0% 10,535 7,636 2,660
10,987
95.5%74,615
23,351
101.3% 98.2%36,524
8,195
99.5% 36,710 8,57916,160
89 100.6%16,071 Hon Mirin
ᇞ 529
5,309
409 108.3%4,900
5,554
5,901
346183 101.6% 11,438 101.2%
168,800
11,622
2,011 104,818 116.0%2,325
5,057
7,619
103.9%ᇞ 16 99.8%
101.3% 1,381
2,764
5,794
79,300
28,700
50,600
前期対比 前期対比
Change from FY2008 Change from FY2008(1st Half)
104 5,720 2,004 106.2% 5,411 73 320
2,957
104.3% 100.7% 100.1% 367研究開発費
商標使用料
管理費
そ
他
販売費及び一般管理費
営業利益
△:損失
営業外収益
営業外費用
経常利益
△:損失
特
利益
特
損失
法人税
民税及び事業税
法人税等調整額
少数株主利益
△:損失
設備投資額
形
無形
減価償却費
形
無形
Net income(△:loss) SG&A expenses
当期純利益
△:損失
Extraordinary gain Extraordinary loss
Current income taxes
税金等調整前当期純利益
△:損失
Minority interests in net income △:loss
Income(△:loss) before income taxes and minority interests Non-operating income
Non-operating expenses
Ordinary income(△:loss)
Other,net
Operating income(△:loss) Research and development License for use of trademarks
ᇞ 319 Deferred income taxes
3,500
385 112.4%3,433 Sales promotion and allowance for s.p.
245
200
ᇞ 45 81.5% 124100
ᇞ 24 80.2%ᇞ 133
1,200
304 134.1%1,028
231 ᇞ 31 86.3% -
113.9% 2,106
7,600
633 109.1%105 242
2,400
6,966 293
57
0
ᇞ 8282
200
283.1%
7,500
407 105.7%300
525.5% 98.5% 2,13267.2% 297
7,500
322 104.5%67.4%
76.9%
650 ᇞ 97
564 ᇞ 96
7,092
7,177 ᇞ 32
ᇞ 32 296
ᇞ 150
3,607 1,086
1,100
13 101.2%2,100
98.5%2,132
300
194169
7,328
3,900
292 108.1%500
ᇞ 64 88.6%500
ᇞ 292 98.9% 26,892
98.4% 111.8%
55,100
307 100.6%54,792
20
ᇞ 120 3 49
ᇞ 206 350 14,858 1,469 114.0% 98.6% 101.6% 23
400
14,652
1,493
695190
- - 927Capital expenditures 2,229
2,600
370 116.6%-
ᇞ 89 95.3% 1,889
Depreciation 3,890
3,800
ᇞ 90 97.7%1,800
26,600
2,100
200
200
7,207
698
100.5%タ
バ
:Takara Bio Group百万 :Millions of Yen
成
成
成 成期実績
期
想
中間期実績 中間期 想FY2008 FY2009 増減 比 FY2008(1
st
Half)FY2009(1st Half)
増減 比
Actual Forecast change % Actual Forecast change %
研究用試薬
理化学機器
託
そ
他フ
ン
遺伝子工学研究
計
遺伝子医療
医食品バ
売
高
売
原価
売
総利益
運
費
保管料
広告
伝費
研究開発費
商標使用料
95.4% 5
License for use of trademarks
100.1% 105.3% 1,968
197
270
72 136.5%ᇞ 25 97.3% 965
130
ᇞ 99 56.7%2,073
104 229 101.9% 5,901 1,343 8,328ᇞ 39 63.5% 108
12,963
2,538
102.1% 95.5% 110ᇞ 203 12,692 2,657 2,730 100.1%
2,594
270ᇞ 119
ᇞ 136
18,096
15ᇞ 45
ᇞ 202
10,055 ᇞ 646 93.6% 21
20,300
1,083 4,634 95.0% 95.8% 84.8%10,223 ᇞ 55 98.8%
20,278
18,080 ᇞ 136 98.4%
33
96.8% 97.9%
4,768
9,409
10,890
666 106.5%ᇞ 146 9,403
1,211
3,906
10
10153
118.5% 95.0% 92 95 609 0 68 287 0 60 1,115 3,296 254.6% 108.6% 136.1% 361.9% 113.4% 119.9% 94 26 69 1,444 Transportation and storageAdvertising Sales promotion
販売
進費
Research and development Research reagents
Cost of sales Gross profit
Contracted service and other Scientific instruments
Net sales
Genetic engineering research segment Gene medicine segment
Agribio segment
6,012
1,140
1,038
8,192
69
940
5089,201
4,488
4,713
128
96
577
前期対比 前期対比
Change from FY2008 Change from FY2008(1st
Half)
1,732
5
管理費
そ
他
販売費及び一般管理費
遺伝子医療
医食品バ
共通
営業利益
△:損失
営業外収益
営業外費用
経常利益
△:損失
特
利益
特
損失
法人税
民税及び事業税
法人税等調整額
少数株主利益
△:損失
設備投資額
形
無形
減価償却費
形
無形
License for use of trademarks
ᇞ
1,681
ᇞ 461 -Gene medicine segment
ᇞ 436 75.8% 1,802
Genetic engineering research segment
遺伝子工学研究
4,054
ᇞ114 97.2%
4,168
1,366
84 112.0% 706
Depreciation 1,429
1,671
241 116.9%Capital expenditures 1,505
1,288
ᇞ 217 85.5% 742 - -5,240
1864,983
114.2% 4,535
107.6%
679 6 ᇞ 394 -
2,456
250
ᇞ 429 36.8%10,790
1,126 111.7% 105.2% 25682 ᇞ 50
126
24
646 9,663 32.3% 74 560ᇞ 66 65.3% 192
279
ᇞ 119 70.1% 398351
100
ᇞ 460 17.9%29
ᇞ 53 35.4%1,196
ᇞ 701 -
232
350
ᇞ 526 40.0%876 ᇞ 718 -
1,400 1,212 ᇞ 1,199 1.1%
ᇞ 719 -
719
36
ᇞ 1,364 2.6%0
ᇞ 1,196 -- ᇞ 142
ᇞ 263 ᇞ 217
314
ᇞ 357 46.7% 67171 -
246
ᇞ 237
154
9
9
0 92.6% 14
2 200.1%ᇞ 352
ᇞ 782
ᇞ
299
ᇞ 110 - ᇞ 811
-
67
ᇞ 1,219 ᇞ 405 ᇞ 207 -
53 -
54
ᇞ
922
Non-operating income Non-operating expenses
Ordinary income(△:loss)
Other,net
Operating income(△:loss)
Net income(△:loss) SG&A expenses
当期純利益
△:損失
Extraordinary gain Extraordinary loss
Current income taxes Deferred income taxes
税金等調整前当期純利益
△:損失
Minority interests in net income △:loss
Income(△:loss) before income taxes and minority interests
Agribio segment
ᇞ
487
295 -Eliminations/Corporate ᇞ 1,607